Emerging Implant Technologies received FDA approval for its full 3-D printed cage portfolio.
Here are four things to know:
1. The company can now commercialize its spinal interbody products for anterior lumbar interbody fusion, transforaminal lumbar interbody fusion, posterior lumbar interbody fusion and cervical procedures.
2. The company's implants are composed of EIT Cellular Titanium, which features optimal pore shape and size to encourage bone ingrowth.
3. EIT leverages metal 3-D printing Selective Laser Melting technology in combination with proprietary post-processing methods to build a porous, osteo-influential titanium scaffold for osseointegration.
4. Providers have use the EIT Cellular Titanium Interbody cages in more than 10,000 cases in more than 15 countries.
"This is a major milestone for EIT. We look forward to bringing our unique technologies to the United States and partnering with top tier surgeons and institutions to bring the best results to patients that are in need of these devices," said Guntmar Eisen, co-founder and CEO of EIT.